 | • レポートコード：MRC2-11QY12067 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は淋病治療薬のグローバル市場について調査・分析したレポートです。種類別（単剤療法、二重療法）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別淋病治療薬の競争状況、市場シェア ・世界の淋病治療薬市場：種類別市場規模 2015年-2020年（単剤療法、二重療法） ・世界の淋病治療薬市場：種類別市場規模予測 2021年-2026年（単剤療法、二重療法） ・世界の淋病治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界の淋病治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米の淋病治療薬市場分析：米国、カナダ ・ヨーロッパの淋病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの淋病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の淋病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの淋病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bharat Pharmaceuticals、GlaxoSmithKline、Merck、Pfizer、Alopexx Pharmaceuticals、AstraZeneca、Debiopharm Group、Melinta Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospects.
The latest trend gaining momentum in the market is Advent of vaccine for prevention of gonorrhea. Gonorrhea is a major public health concern globally. It is considerably affecting the reproductive health of people and increasing the spread of human immunodeficiency virus (HIV). The currently available treatment regimen is unsuccessful in controlling the spread of Neisseria gonorrhoeae due to the rapid emergence of the antibiotic-resistant strains of this bacterium. Therefore, the prevention of the disease seems to be a more appropriate approach for controlling the spread of Neisseria gonorrhoeae.
Market Analysis and Insights: Global Gonorrhea Therapeutics Market
The global Gonorrhea Therapeutics market size is projected to reach US$ 1084.9 million by 2026, from US$ 1040 million in 2020, at a CAGR of 4.0%% during 2021-2026.
Global Gonorrhea Therapeutics Scope and Market Size
Gonorrhea Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gonorrhea Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bharat Pharmaceuticals
GlaxoSmithKline
Merck
Pfizer
Alopexx Pharmaceuticals
AstraZeneca
Debiopharm Group
Melinta Therapeutics
Market segment by Type, the product can be split into
Monotherapy
Dual Therapy
Market segment by Application, split into
Clinics
Hospitals
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gonorrhea Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monotherapy
1.4.3 Dual Therapy
1.5 Market by Application
1.5.1 Global Gonorrhea Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Gonorrhea Therapeutics Market Perspective (2015-2026)
2.2 Global Gonorrhea Therapeutics Growth Trends by Regions
2.2.1 Gonorrhea Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gonorrhea Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Gonorrhea Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gonorrhea Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Gonorrhea Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gonorrhea Therapeutics Players by Market Size
3.1.1 Global Top Gonorrhea Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Gonorrhea Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Gonorrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gonorrhea Therapeutics Market Concentration Ratio
3.2.1 Global Gonorrhea Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gonorrhea Therapeutics Revenue in 2019
3.3 Gonorrhea Therapeutics Key Players Head office and Area Served
3.4 Key Players Gonorrhea Therapeutics Product Solution and Service
3.5 Date of Enter into Gonorrhea Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gonorrhea Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Gonorrhea Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Gonorrhea Therapeutics Market Size by Application (2015-2020)
5.2 Global Gonorrhea Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gonorrhea Therapeutics Market Size (2015-2020)
6.2 Gonorrhea Therapeutics Key Players in North America (2019-2020)
6.3 North America Gonorrhea Therapeutics Market Size by Type (2015-2020)
6.4 North America Gonorrhea Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gonorrhea Therapeutics Market Size (2015-2020)
7.2 Gonorrhea Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Gonorrhea Therapeutics Market Size by Type (2015-2020)
7.4 Europe Gonorrhea Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Gonorrhea Therapeutics Market Size (2015-2020)
8.2 Gonorrhea Therapeutics Key Players in China (2019-2020)
8.3 China Gonorrhea Therapeutics Market Size by Type (2015-2020)
8.4 China Gonorrhea Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gonorrhea Therapeutics Market Size (2015-2020)
9.2 Gonorrhea Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Gonorrhea Therapeutics Market Size by Type (2015-2020)
9.4 Japan Gonorrhea Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gonorrhea Therapeutics Market Size (2015-2020)
10.2 Gonorrhea Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gonorrhea Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Gonorrhea Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Gonorrhea Therapeutics Market Size (2015-2020)
11.2 Gonorrhea Therapeutics Key Players in India (2019-2020)
11.3 India Gonorrhea Therapeutics Market Size by Type (2015-2020)
11.4 India Gonorrhea Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gonorrhea Therapeutics Market Size (2015-2020)
12.2 Gonorrhea Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Gonorrhea Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Gonorrhea Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bharat Pharmaceuticals
13.1.1 Bharat Pharmaceuticals Company Details
13.1.2 Bharat Pharmaceuticals Business Overview
13.1.3 Bharat Pharmaceuticals Gonorrhea Therapeutics Introduction
13.1.4 Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2015-2020))
13.1.5 Bharat Pharmaceuticals Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Gonorrhea Therapeutics Introduction
13.2.4 GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Gonorrhea Therapeutics Introduction
13.3.4 Merck Revenue in Gonorrhea Therapeutics Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Gonorrhea Therapeutics Introduction
13.4.4 Pfizer Revenue in Gonorrhea Therapeutics Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Alopexx Pharmaceuticals
13.5.1 Alopexx Pharmaceuticals Company Details
13.5.2 Alopexx Pharmaceuticals Business Overview
13.5.3 Alopexx Pharmaceuticals Gonorrhea Therapeutics Introduction
13.5.4 Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2015-2020)
13.5.5 Alopexx Pharmaceuticals Recent Development
13.6 AstraZeneca
13.6.1 AstraZeneca Company Details
13.6.2 AstraZeneca Business Overview
13.6.3 AstraZeneca Gonorrhea Therapeutics Introduction
13.6.4 AstraZeneca Revenue in Gonorrhea Therapeutics Business (2015-2020)
13.6.5 AstraZeneca Recent Development
13.7 Debiopharm Group
13.7.1 Debiopharm Group Company Details
13.7.2 Debiopharm Group Business Overview
13.7.3 Debiopharm Group Gonorrhea Therapeutics Introduction
13.7.4 Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2015-2020)
13.7.5 Debiopharm Group Recent Development
13.8 Melinta Therapeutics
13.8.1 Melinta Therapeutics Company Details
13.8.2 Melinta Therapeutics Business Overview
13.8.3 Melinta Therapeutics Gonorrhea Therapeutics Introduction
13.8.4 Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2015-2020)
13.8.5 Melinta Therapeutics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Gonorrhea Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Gonorrhea Therapeutics Revenue
Table 3. Ranking of Global Top Gonorrhea Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gonorrhea Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monotherapy
Table 6. Key Players of Dual Therapy
Table 7. Global Gonorrhea Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Gonorrhea Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Gonorrhea Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Gonorrhea Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Gonorrhea Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Gonorrhea Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Gonorrhea Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Gonorrhea Therapeutics Players
Table 18. Global Gonorrhea Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Gonorrhea Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Gonorrhea Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gonorrhea Therapeutics as of 2019)
Table 21. Global Gonorrhea Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gonorrhea Therapeutics Product Solution and Service
Table 24. Date of Enter into Gonorrhea Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gonorrhea Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Gonorrhea Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Gonorrhea Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Gonorrhea Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Gonorrhea Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Gonorrhea Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Gonorrhea Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Gonorrhea Therapeutics Market Share (2019-2020)
Table 34. North America Gonorrhea Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Gonorrhea Therapeutics Market Share by Type (2015-2020)
Table 36. North America Gonorrhea Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Gonorrhea Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Gonorrhea Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Gonorrhea Therapeutics Market Share (2019-2020)
Table 40. Europe Gonorrhea Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Gonorrhea Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Gonorrhea Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Gonorrhea Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Gonorrhea Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Gonorrhea Therapeutics Market Share (2019-2020)
Table 46. China Gonorrhea Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Gonorrhea Therapeutics Market Share by Type (2015-2020)
Table 48. China Gonorrhea Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Gonorrhea Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Gonorrhea Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Gonorrhea Therapeutics Market Share (2019-2020)
Table 52. Japan Gonorrhea Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Gonorrhea Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Gonorrhea Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Gonorrhea Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Gonorrhea Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Gonorrhea Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Gonorrhea Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Gonorrhea Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Gonorrhea Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Gonorrhea Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Gonorrhea Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Gonorrhea Therapeutics Market Share (2019-2020)
Table 64. India Gonorrhea Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Gonorrhea Therapeutics Market Share by Type (2015-2020)
Table 66. India Gonorrhea Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Gonorrhea Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Gonorrhea Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Gonorrhea Therapeutics Market Share (2019-2020)
Table 70. Central & South America Gonorrhea Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Gonorrhea Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Gonorrhea Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Gonorrhea Therapeutics Market Share by Application (2015-2020)
Table 74. Bharat Pharmaceuticals Company Details
Table 75. Bharat Pharmaceuticals Business Overview
Table 76. Bharat Pharmaceuticals Product
Table 77. Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2015-2020) (Million US$)
Table 78. Bharat Pharmaceuticals Recent Development
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Product
Table 82. GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2015-2020) (Million US$)
Table 83. GlaxoSmithKline Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Product
Table 87. Merck Revenue in Gonorrhea Therapeutics Business (2015-2020) (Million US$)
Table 88. Merck Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Gonorrhea Therapeutics Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Alopexx Pharmaceuticals Company Details
Table 95. Alopexx Pharmaceuticals Business Overview
Table 96. Alopexx Pharmaceuticals Product
Table 97. Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2015-2020) (Million US$)
Table 98. Alopexx Pharmaceuticals Recent Development
Table 99. AstraZeneca Company Details
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Product
Table 102. AstraZeneca Revenue in Gonorrhea Therapeutics Business (2015-2020) (Million US$)
Table 103. AstraZeneca Recent Development
Table 104. Debiopharm Group Company Details
Table 105. Debiopharm Group Business Overview
Table 106. Debiopharm Group Product
Table 107. Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2015-2020) (Million US$)
Table 108. Debiopharm Group Recent Development
Table 109. Melinta Therapeutics Business Overview
Table 110. Melinta Therapeutics Product
Table 111. Melinta Therapeutics Company Details
Table 112. Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2015-2020) (Million US$)
Table 113. Melinta Therapeutics Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gonorrhea Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Monotherapy Features
Figure 3. Dual Therapy Features
Figure 4. Global Gonorrhea Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Clinics Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Others Case Studies
Figure 8. Gonorrhea Therapeutics Report Years Considered
Figure 9. Global Gonorrhea Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Gonorrhea Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Gonorrhea Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Gonorrhea Therapeutics Market Share by Players in 2019
Figure 14. Global Top Gonorrhea Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gonorrhea Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Gonorrhea Therapeutics Revenue in 2019
Figure 16. North America Gonorrhea Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Gonorrhea Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Gonorrhea Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Gonorrhea Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Gonorrhea Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Gonorrhea Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Gonorrhea Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
淋病診断の世界市場（～2026年） Gonorrhea, also spelled gonorrhoea, is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. Global gonorrhea diagnostic market is expected to witness a significant growth during the forecast period owing to the growing prevalence of the disease worldwide and unmet ne…- 淋病検査の世界市場（～2026年） Most of the time, urine can be used to test forgonorrhea. However, if you have had oral and/or anal sex, swabs may be used to collect samples from your throat and/or rectum. In some cases, a swab may be used to collect a sample from a man's urethra (urine canal) or a woman's cervix (opening to the w…
- 淋病検査サービスの世界市場（～2026年） Market Analysis and Insights: Global Gonorrhea Testing Services Market The global Gonorrhea Testing Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gonorrhea Testing Services Scope and Market Size Gonorrhea Te…
- リソソーム蓄積症（LSD）治療薬の世界市場（～2026年） Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells. The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market. Market Analysis and Insights: Glob…
- 皮膚糸状菌性爪真菌症治療薬（DOT）の世界市場（～2026年） Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs.…